Title:
ニコチンアミドリボシド、ニコチン酸リボシド、ニコチンアミドモノヌクレオチド、およびニコチノイル化合物誘導体の、乳児用粉ミルクへの使用
Document Type and Number:
Japanese Patent JP7223110
Kind Code:
B2
Abstract:
Infant formula compositions and methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.
More Like This:
Inventors:
Dellinger, Ryan
Lonemouth, Troy
Morris mark
Kotse, Dietrich
Bowie, Emmy
Lonemouth, Troy
Morris mark
Kotse, Dietrich
Bowie, Emmy
Application Number:
JP2021211442A
Publication Date:
February 15, 2023
Filing Date:
December 24, 2021
Export Citation:
Assignee:
ChromaDex,Inc.
International Classes:
A23L33/13; A23C9/152; A23C9/158; A23K20/132; A23K20/153; A23K20/174; A23L33/15; A23L33/19; A61K9/14; A61K31/4415; A61K31/455; A61K31/51; A61K31/525; A61K31/706; A61K35/20; A61K38/17; A61P1/00; A61P1/04
Domestic Patent References:
JP2015519388A |
Foreign References:
US20100104727 |
Other References:
ChromaDex Introduces NIAGEN - The First and Only Commercially Available Nicotinamide Riboside,Nutrition insight [online],2013年06月03日,, [検索日:2020年9月8日]
Frontiers in Microbiology,2016年02月17日,7,185
Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells,Journal of Biological Chemistry,2015年,290(45),27124-27137
Frontiers in Microbiology,2016年02月17日,7,185
Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells,Journal of Biological Chemistry,2015年,290(45),27124-27137
Attorney, Agent or Firm:
Patent business corporation Kita Aoyama International
Previous Patent: Removal mechanism and removal method
Next Patent: CUTTING DEVICE FOR THIN METAL PIPE
Next Patent: CUTTING DEVICE FOR THIN METAL PIPE